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Abstract
Background: Redox active minerals in dietary supplements can catalyze unwanted and potentially harmful
oxidations.
Methods: To determine if this occurs in vivo we employed electron paramagnetic (EPR) imaging. We used
1-hydroxy-3-carboxy- 2,2,5,5-tetramethylpyrrolidine (CPH) as a reporter for one-electron oxidations, e.g. free
radical-mediated oxidations; the one-electron oxidation product of CPH, 3-carboxy-2,2,5,5-tetramethyl-1-
pyrrolidinyloxy (CP●), is a nitroxide free radical that is relatively persistent in vivo and detectable by EPR. As
model systems, we used research formulations of vitamin mineral supplements (RVM) that are typical of
commercial products.
Results: In in vitro experiments, upon suspension of RVM in aqueous solution, we observed: (1) the uptake of
oxygen in the solution, consistent with oxidation of the components in the RVM; (2) the ascorbate free
radical, a real-time indicator of ongoing oxidations; and (3) when amino acid/oligosaccharide (AAOS; glycinate
or aspartate with non-digestible oligofructose) served as the matrix in the RVM, the rate of oxidation was
significantly slowed. In a murine model, EPR imaging showed that the ingestion of RVM along with CPH
results in the one-electron oxidation of CPH by RVM in the digestive system. The resulting CP● distributes
throughout the body. Inclusion of AAOS in the RVM formulation diminished the oxidation of CPH to CP● in
vivo.
Conclusions: These data demonstrate that typical formulations of multivitamin/multimineral dietary
supplements can initiate the oxidation of bystander substances and that AAOS-complexes of essential redox
active metals, e.g. copper and iron, have reduced ability to catalyze free radical formation and associated
detrimental oxidations when a part of a multivitamin/multimineral formulation.
Keywords: Vitamins, Minerals, Electron paramagnetic resonance, Free radical, Ascorbate, Imaging, Oxidation
Background
Although nutritional supplements are not intended to
substitute for a healthy, varied diet, millions of people
complement their daily food intake with dietary supple-
ments to ensure adequate intake of essential nutrients
required for optimal health. Formulations of multivita-
min supplements typically include oxidation-sensitive vi-
tamins, such as vitamins C and E, as well as redox active
minerals, such as iron and copper. These redox active
transition metals can serve as catalysts for the oxidation
of organic compounds. For example, adventitious, trace
levels of iron and copper in near-neutral phosphate buf-
fer readily catalyze the oxidation of ascorbate [1–3].
Ferric iron is a standard reagent used to oxidize tocoph-
erols to their corresponding quinones [4], which are
inactive as antioxidants; in fact quinones can function
as pro-oxidants [5, 6]. The combination of these min-
erals and ascorbate in dietary supplements can catalyze
unwanted and potentially harmful oxidations [3, 7–10].
For example, the metal-catalyzed oxidation of ascorbate
can lead to the oxidation of substances and structures in
cells and tissues [3, 11]. The combination of iron and* Correspondence: arabovsky@melaleuca.com1Research & Development, Melaleuca Inc, 4609 West 65th South, Idaho Falls,
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ascorbate, referred to as the Udenfriend system, is a
standard approach to oxidize organic substances [12].
Thus, these metals could bring about the loss of anti-
oxidants as well as initiate potentially harmful oxida-
tion reactions in cells and tissues before absorption
by the digestive system.
Because we had previously observed that dietary
supplements can catalyze oxidations in vitro [10], we
hypothesized that similar oxidations could also occur
in vivo. Here we prepared research multivitamin/multi
mineral formulations (RVM) based on RDA guidelines
with minerals as typical inorganic complexes or with
amino acid/oligosaccharide (AAOS; glycinate or aspar-
tate with non-digestible oligofructose) serving as the
coordinating ligands and matrix for the minerals in
the RVM. The abilities of these formulations to initi-
ate oxidation processes in vitro and in vivo were ex-
amined. As reporters on these oxidations, we used
oxygen uptake, ascorbate radical formation, and the
oxidation of CPH to CP●, which can be monitored by
EPR both in vitro and in vivo. The oxidation of CPH
to CP● reports on one-electron (free radical) oxida-
tions. We used EPR imaging to determine if formula-
tions of multivitamin/multimineral supplements can
initiate free radical oxidations in vivo.
Methods
Materials
Oxygen-Sensitive Label (OSL; tetrathiatriarylmethyl rad-
ical), CPH (1-hydroxy-3-carboxy- 2,2,5,5-tetramethylpyr-
rolidine), CP● (3-carboxy-2,2,5,5-tetramethyl-1-pyrrolidi
ne-1-oxyl, CAS# 50525-83-2 and 2154-68-9), CAT1-H
(1-hydroxy-2,2,6,6-tetramethylpiperidin-4-yl-trimethylammo-
nium chloride•HCl), DFO (deferoxamine, methanesulfonate
salt, CAS# 138-14-7), DETC (diethyldithiocarbamic
acid, sodium salt trihydrate CAS# 20624-25-3), and
Teflon® microtubes (50 μL) were from Noxygen
Science Transfer & Diagnostics, GmbH, Elzach,
Germany. The amino acid/oligosaccharide (AAOS;
glycinate or aspartate with non-digestible oligofruic-
tose) serving as the matrix for the minerals were pre-
pared as previously described [10].
RVM formulation
Two formulations of the research vitamins and min-
erals (RVM) were prepared with identical content of
vitamins and excipients; the two formulations differed
only by the sources of mineral: AAOS or inorganic
(sulfates, chlorides, and oxides), Table 1. Vitamin A,
vitamin C, vitamin D, vitamin E, vitamin K, thiamin,
riboflavin, niacin, vitamin B6, folate, vitamin B12, bio-
tin, pantothenic acid, microcrystalline cellulose, cros-
caramellose sodium, silicone dioxide, magnesium
stearate, and carnauba wax were purchased from






Vitamin A (as beta carotene) 5000 IU 100 %
Vitamin C (as ascorbic acid) 60 mg 100 %
Vitamin D (as cholecalciferol) 400 IU 100 %
Vitamin E (as d-alpha tocopheryl
succinate)
30 IU 100 %
Vitamin K (as phytonadione) 80 μg 100 %
Thiamin (as thiamin HCl) 1.5 mg 100 %
Riboflavin 1.7 mg 100 %
Niacin (as niacinamide) 20 mg 100 %
Vitamin B6 (as pyridoxine HCl) 2 mg 100 %
Folate (as folic acid) 400 μg 100 %
Vitamin B12 (as cyanocobalamin) 6 μg 100 %
Biotin (as d-biotin) 300 μg 100 %
Pantothenic Acid (as calcium
pantothenate)
10 mg 100 %
Calcium (as calcium carbonate) 100 mg 10 %
Magnesium (as magnesium oxide) 40 mg 10 %
Iodine (as potassium iodide) 150 μg 100 %
Microcrystalline cellulose 121 mg nab
Croscaramellose sodium 12 mg na
Silicone dioxide 12 mg na
Magnesium stearate 4 mg na
Carnauba wax 0.14 mg na
RVM #1- Inorganic
Iron (as iron sulfate) 18 mg 100 %
Zinc (as zinc sulfate) 15 mg 100 %
Selenium (as L-selenomethionine) 70 μg 100 %
Copper (as copper sulfate) 2 mg 100 %
Manganese (as manganese sulfate) 2 mg 100 %
Chromium (as chromium chloride) 120 μg 100 %
Molybdenum (as sodium molybdate) 75 μg 100 %
RVM #2- AAOS
Iron (as iron AAOS) 18 mg 100 %
Zinc (as zinc AAOS) 15 mg 100 %
Selenium (as selenium AAOS) 70 μg 100 %
Copper (as copper AAOS) 2 mg 100 %
Manganese (as manganese AAOS) 2 mg 100 %
Chromium (as chromium AAOS) 120 μg 100 %
Molybdenum (as molybdenum
AAOS)
75 μg 100 %
a% Daily Values (%DV) are based on Daily Value recommendations for key
nutrients based on 2000 cal daily diet
bna is not applicable
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Sigma Chemical, Co., St. Louis, MO. Calcium carbon-
ate, magnesium oxide, potassium iodide, copper sul-
fate, copper gluconate, iron sulfate, zinc sulfate,
manganese sulfate, chromium chloride, and sodium
molybdate were purchased from Spectrum Chemicals
and Laboratory Products, New Brunswick, NJ.
The research multivitamin/multi mineral formula-
tions were prepared based on RDA guidelines (Daily
Values for Nutrition Labeling, 21 CFR §101.9(c) and
CFR §101.36(b)(2)(ii)(B)) [13]. In addition to the active
ingredients, typical excipients used in the tablet pressing
and coating process included: microcrystalline cellulose,
croscaramellose sodium, magnesium stearate, silicon diox-
ide, coating cellulose, and carnauba wax.
Supplement manufacturers often split multivitamins
and multi minerals into two supplements, thereby
allowing them to include all ingredients at a level of
100 % Daily Value (DV). If this is not the case, they
will commonly decrease the level of select minerals to
avoid tablets or capsules that are too large for con-
sumer comfort. Here, the redox inactive minerals, mag-
nesium and calcium, are only at 10 % DV in the RVMs
formulated for this study.
Kinetics of oxygen consumption and ascorbate oxidation
Formulation powders (150 mg) were suspended in
20 mL of 100 mM HCl. The suspension was then mixed
for 5 min at room temperature with the pH being main-
tained at 2.5 ± 0.2 by addition of HCl. Aliquots were
then mixed with Oxygen-Sensitive Label and subse-
quently diluted with carbonate buffer (50 mM, pH 7.2).
The final concentrations of copper and iron were 26 and
270 μM, respectively; the final concentration of OSL was
4 μM. The suspension was transferred to a 50 μL glass
micropipette (Hirschmann Laborgeräte GmbH & Co.
KG, Eberstadt, Germany); ascorbate radical and oxygen
consumption were monitored simultaneously. The initial
concentration of oxygen in the air-saturated aqueous
solutions of these experiments was taken as 210 μM
(altitude of 1445 m) [14].
A Bruker E-SCAN EPR spectrometer with a
Temperature and Gas Controller (BIO III, Noxygen
Science Transfer & Diagnostics, GmbH, Elzach,
Germany) was used to monitor oxygen consumption
and the changes in the concentration of ascorbate
free radical. EPR spectrometer settings were: center
field g = 2.01; microwave power, 20 mW; modulation
amplitude, 0.98 G; sweep rate, 10 G/5.24 s; number
of scans, 3; for 1024-point spectrum.
CPH oxidation to CP● in vitro
Stock solutions of CPH were prepared in Krebs HEPES
buffer and stored at −80 °C. CPH working solution was
prepared in carbonate buffer (50 mM, pH 7.2)
containing CPH (200 μM), DFO (25 μM), and DETC
(5 μM)–final concentrations quoted. Powders were pre-
pared as described in “Kinetics of oxygen consumption
and ascorbate oxidation”. Suspensions were transferred
to a 50 μL Teflon microtube. Spectra were collected with
a Bruker E-SCAN spectrometer equipped with a
Temperature & Gas Controller (Noxygen GmbH,
Germany). EPR instrument settings were: center field, g
= 2.01; microwave power, 20 mW; modulation ampli-
tude, 2.2 G; sweep rate, 80 G/5.24 s; number of scans,
10; a 1024-point spectrum; total experimental time,
≈28 min. Temperature and Gas Controller parameters
were: temperature, 37 °C; pressure, 25 mmHg; oxygen,
7.4 %; and carbon dioxide, 0.5 %.
Free radical formation in vivo
C57BL/6J mice (7- to 8-week old, 8 groups, 5 per
group) were used to examine free radical formation
in vivo by the different RVM formulations. Animals
were handled in accordance with the Animal
Welfare Act (AWA) (7 U.S.C. § 2131) and the
German Animal Welfare Act (Tierschutzgesetz); all
protocols were approved by the regional commission
Emmendingen for animal care under registration
number DE08316100121 accordingly § 3 of regula-
tion #1069/2009.
RVM formulations were powdered and then sus-
pended in 0.9 % NaCl solution (pH ≤ 3) containing
CPH at a final concentration of 1 mM; e.g. 3.57 mg of
RVM/200 μL for a 25 g mouse, the exact amount of
RVM was adjusted for the actual weight of the mouse.
This amount corresponds to approximately 10 times
the recommended dose for humans. The oxygen ten-
sion in this mixture was adjusted to 40 mmHg of oxy-
gen, typical of the concentration of oxygen in the
digestive system [unpublished data obtained in the
Noxygen Science Transfer & Diagnostics GmbH
laboratories]. The RVM suspension (200 μL) was im-
mediately administered by oral gavage. Fifteen min
after administration of the RVM/CPH mixture, mice
were sacrificed without pain in compliance with
Tierschutzgesetz guidelines for harvesting samples of
gastric, intestine, and bladder fluids as well as sam-
ples of venous blood taken from the right heart ven-
tricle. Equal volumes (30 μL) of collected samples
were analyzed using a BenchTop EPR spectrometer E-
Scan (Noxygen Science Transfer & Diagnostics
GmbH, Germany) for the level of CP-radical (CP●).
The EPR instrument settings were: center field, g =
2.01; field sweep, 60 G; microwave power, 20 mW;
magnetic field modulation, 100 MHz; modulation
amplitude, 2.0 G; conversion time, 80.24 ms; detector
time constant, 20.96 ms; and sweep time, 60 s.
Rabovsky et al. BMC Nutrition  (2015) 1:32 Page 3 of 9
To verify the distribution of CP● into the blood stream
as well as determine the nonspecific oxidation of CPH
we administered to two groups of mice by oral gavage
solutions of 1.0 mM of CP● or CPH (200 μL per 20 g
BW) containing no RVM.
EPR imaging of free radical formation in vivo
C57BL/6J mice (7- to 8-week old) were used to image
in vivo free radical formation, i.e. formation of CP●, by
the different RVM formulations (amounts and concen-
trations were the same as described above). Five and
20 min after administration of the RVM/CPH mixture
the digestive system was imaged using an L-Band
EPR-Spectrometer ELEXSYS E540 (Bruker Biospin
GmbH, Germany). Before and during data acquisition
mice were anesthetized using 2.2 % isoflurane. Mice
were positioned in a 36 mm small-animal cavity
equipped with an automatic matching control system.
EPR instrument settings were: center field, g = 2.01;
field sweep, 60 G; microwave power, 40 mW; magnetic
field modulation, 1 GHz; modulation amplitude, 3.0 G;
conversion time, 20.24 ms; detector time constant,
40.96 ms; image field of view, 25 mm; acquired angles,
31; gradient, 24 G/cm. The 2D EPR image was con-
structed employing the following strategies: zeroth-
order baseline correction; FT deconvolution using a




It is not possible to compare directly the potential
oxidative chemistry of different multivitamins/min-
erals supplements that are on the market due to in-
terferences from the different matrices of the
formulations. To overcome this barrier, research for-
mulations (RVM) were prepared with identical
matrices and vitamin content, differing only in the
forms of minerals included in the formulations,
Table 1. Using these formulations we examined the
oxidations initiated by these formulations in vitro
and in vivo.
Oxygen uptake by RVM formulations
Because the uptake of oxygen is at the foundation of
oxidation processes we monitored the rate of loss of
oxygen in aqueous suspensions of RVM formula-
tions. The concentration of oxygen in aqueous solu-
tion can be monitored by several approaches,
including EPR [15]. Because the OSL did not react
with the materials in the RVM suspensions, we used
the OSL EPR signal amplitude as a measure of the
oxygen concentration in solution, Fig. 1 [16–18].
The rates of oxygen uptake by the RVM formula-
tions in near-neutral solutions were approximately
linear until the concentration reached approximately
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Fig. 1 The ascorbate free radical and OSL can be monitored simultaneously by EPR. The spectra of ascorbate free radical (g = 2.005, aH = 1.8 G)
and the oxygen sensitive label (tetrathiatriarylmethyl radical; g = 2.003) have no significant overlap and their concentrations are low enough so
that each can be analyzed independently without concern of interactions
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rate of oxidation by more than 50 % compared to
the inorganic formulation of RVM (d[O2]/dt = −280
nM s−1 for the inorganic RVM vs. only −120 nM s−1
for the AAOS RVM.
RVM results in formation and rapid loss of Asc•-
The ascorbate radical and OSL can be monitored
simultaneously by EPR, Fig. 1. Because the concen-
tration of each radical is low (4 μM or less) and
there is no significant spectral overlap, spectral ana-
lysis can be made without concern for interactions.
RVM solutions showed the presence of the ascorbate
free radical, a marker for the ongoing oxidation of
ascorbate [19]. If the radical flux is low compared to
ascorbate (i.e. the oxidizing free radical is the “limit-
ing reagent”), then the ascorbate radical is an excel-
lent measure of the ongoing flux of oxidants in the
system; however, if the ascorbate is a limiting re-
agent, then it will be rapidly consumed with an asso-
ciated decrease in the ascorbate radical over time.
We observed that both RVM formulations resulted
in a time-dependent loss of the EPR signal of the as-
corbate free radical. However, the rate of loss of as-
corbate radical with the inorganic formulation of
RVM was more than six times greater than with the
AAOS formulation (−6.5 nM s−1 vs. −1.0 nM s−1),
Fig. 2b.
Informative is that the shapes of the curves for
oxygen consumption and loss of ascorbate radical
had parallels; initially each was approximately linear,
then each had a clear slowing and loss of linearity at
similar times (when approximately 100 μM of dioxy-
gen had been consumed). The initial concentration
of ascorbate in the solution being monitored by EPR
was 60 μM while that of O2 is 210 μM. The
oxidation of ascorbate to dehydroascorbic acid is a
two-electron oxidation; this would result in the stoi-
chiometric loss of 60 μM of O2 if H2O2 is the final
reduction product or 30 μM of O2 if H2O is the
final reduction product. The loss of more than
60 μM indicates that not only ascorbate is being oxi-
dized, but other components of the RVM. Taken to-
gether, both oxygen consumption and the loss of
ascorbate radical are consistent with RVM initiating
oxidation processes in an aqueous environment. The
inorganic formulation of RVM has a much greater
rate of oxidation, demonstrating the importance of
the form of the redox active metals in these
oxidations.
RVM oxidizes CPH by one-electron; CPH
as a tool
In another approach to determine if the RVM for-
mulations can initiate one-electron oxidations we
used the oxidation of a hydroxylamine to its corre-
sponding nitroxide [20–24]. CPH is a five-membered
ring hydroxylamine that can undergo a one-electron
oxidation to its corresponding nitroxide, CP● (Reac-
tion 1), which can be readily observed by EPR. We
chose a five-membered hydroxylamine because its
corresponding nitroxide is more resistant to reduc-
tion than six-membered ring nitroxides [20]; thus,
once the five-membered ring nitroxide is formed it
would be more persistent than a six-membered ring
nitroxide in solutions that contain reducing agents,
such as ascorbate, as well as in vivo. In addition, at
near-neutral pH the carboxyl group will be unproto-
nated, which will influence the distribution of the














































Fig. 2 The rate of oxidation of RVM was greater when formulated with inorganic components compared to AAOS formulations. a rate of oxygen
consumption of the two different formulations of RVM; b rate of loss of ascorbate radical. These results represent the mean and standard error of
3 experiments where loss of oxygen and ascorbate radical were monitored simultaneously by EPR in the samples
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When CPH is included in a near-neutral aqueous
suspension of RVM it undergoes a time-dependent,
one-electron oxidation to CP●, as observed by EPR,
Fig. 3. That the signal increases with time indicates
that oxidations are ongoing, rather than occurring in
a very short burst.
CPH and the membrane non-penetrable probe
CAT1-H was chosen to probe for in vivo oxidations
initiated by RVM. However, the nitroxide radical asso-
ciated with the one-electron oxidation of CAT1-H
could not be observed in the EPR imaging experi-
ments, even at very high doses of RVM (100× daily
human dose equivalent) whereas CP● was readily ob-
served in the EPR imaging experiments. Thus, CPH
was chosen as a reporter molecule for the in vivo im-
aging experiments. CPH is oxidized by RVM and as a
five-membered ring nitroxide CP● is much more re-
sistant than six-membered ring nitroxides (e.g. tempo
and tempol) to reduction back to the corresponding
hydroxylamine by physiological reductants such as
ascorbate [20]; CP● is also more resistant to reduc-
tion than most 5-membered imidazole and di-aza
nitroxides [23].
Oxidation of CPH to CP● by RVM in vivo
Digestive system (Imaging)
To determine if RVM initiates oxidations in vivo, we
















Fig. 3 CPH is oxidized to CP● by inorganic RVM. CPH (200 μM) was included in an aqueous suspension of RVM (pH 7.2) and the formation of CP●
(aN = 16.2 G [25]) was observed by EPR. The intensity of the spectrum of CP● increased with time demonstrating ongoing one-electron oxidation
of CPH in the aqueous suspension of RVM. In the absence of RVM only a very low background spectrum of CP● ([CP●] < 0.1 μM) was observed
that did not change significantly in this same time-frame. Inset: spectra collected over time varied only in intensity with no observable changes in
lineshape consistent with the one-electron oxidation of CPH to CP●, with no other significant chemistry
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of CPH to CP● as a reporter. Water suspensions of
RVM formulations containing CPH were immediately
administered into the digestive system of anesthe-
tized mice by gavage. The mice were then immedi-
ately imaged by EPR, approximately 5 min after
introduction of the materials, Fig. 4. We observed a
higher concentration of CP● in mice given the inor-
ganic formulation of RVM than the formulation
using AAOS, Fig. 5. Interesting was that EPR im-
aging showed that CP● was present not only in the
region of the digestive system but also in other parts
of the image.
Systemic distribution of CP● as seen by ex vivo analysis
Because EPR imaging indicated the presence of CP●
throughout the region being imaged, we examined the
distribution of CP● in the mouse after administration
of RVM/CPH. Fifteen minutes after the introduction
of the RVM formulations into the stomach of the
mice, fluid and organ materials were harvested for
analysis of CP●. The analysis showed wide distribution
of CP●, Table 2 and Fig. 5. Blood had the highest
level of CP●; as expected CP● appeared in bladder
fluid as well as fluids from other organs. The inor-
ganic formulation of RVM resulted in nearly twice
the level of CP● as the AAOS formulation. When
CPH was administered in the absence of RVM, only
very low levels of CP● were observed in all samples,
indicating that the RVM formulations were respon-
sible for the vast majority of CP● that appeared, i.e.
RVM oxidized CPH to of CP● in vivo. When CP●
(only) was administered as a control, a very high level
was seen in stomach fluid and it distributed to other
sites in a pattern similar to that observed by RVM
and CPH.
Because administration of CPH alone as a control
showed very little CP● in all regions tested, the obser-
vation of CP● throughout the mouse is consistent
with RVM initiating oxidations in the digestive sys-
tem. We conclude that the free radicals formed in the
digestive tract by consumed minerals partitioned into
the blood and thereby became distributed throughout
entire body.
Conclusions
We have clearly demonstrated the value of using the
oxidation of CPH to CP● as a reporter for one-
electron oxidations in vitro and in vivo. Using the
rates of oxygen consumption and loss of ascorbate
radical coupled with the oxidation of CPH to CP● we
clearly show that RVM will catalyze the formation of
oxidants. These oxidants initiate the one-electron oxi-
dation of “bystander” species; here as a bystander, the
oxidation of CPH to CP● is followed by EPR. In vivo,
Fig. 4 Configuration and area imaged by EPR to monitor in vivo formation of CP●. Anaesthetized (isoflurane 2.2 %) mice were positioned for
imaging in a 36 mm cavity of L-Band EPR-Spectrometer ELEXSYS E540 equipped with an automatic matching control system. The area for imaging
(30 × 30 mm) was chosen as presented (blue circle with 3 black dots) to capture the digestive system. Acquisition of the spectra for CP● in the digestion
system was performed twice (2 × 10 min). EPR instrument settings were: center field, g = 2.01; field sweep, 60 G; microwave power, 40 mW; magnetic
field modulation, 1 GHz; modulation amplitude, 3.0 G; conversion time, 20.24 ms; detector time constant, 40.96 ms; image field of view, 25 mm;
acquired angles, 31; gradient, 24 G cm−1
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CP● formed by the oxidation of CPH in the stomach
and intestine spreads throughout the body, as demon-
strated by the wide distribution of CP●.
We show that RVM catalyzes oxidations; the rate of
these oxidations can be modulated by the materials
used in the formulation of RVM. When AAOS is
used in the formulation, as apposed to inorganic
forms of minerals, the rate of oxidation in aqueous
suspensions of RVM in vitro is decreased by at least
50 % as determined by the rates of oxygen uptake,
loss of ascorbate radical, and formation of CP●. Real-
time EPR imaging also demonstrates that AAOS
blunts oxidations induced by multivitamin/multimin-
eral supplements in vivo.
These results demonstrate that typical ingredients
of multivitamin/multimineral supplements result in
the oxidation of materials within the formulation as
demonstrated by the oxidation of ascorbate, but also
bystander materials can be oxidized as demonstrated
by the oxidation of CPH to CP●. We clearly show
both in vitro and in vivo that the nature of the co-
ordinating ligands of the redox-active minerals is an
important consideration. We have demonstrated both
in vitro and in vivo that AAOS greatly reduces the
rate of oxidations initiated by the minerals in typical
multivitamin/multimineral supplements.
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